Showing 1 - 7 results of 7 for search 'Jagan A. Pillai', query time: 0.03s
Refine Results
-
1
Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical Outcomes by Jagan A. Pillai, Jagan A. Pillai, Jagan A. Pillai, Maria Khrestian, Maria Khrestian, James Bena, James B. Leverenz, James B. Leverenz, James B. Leverenz, Lynn M. Bekris, Lynn M. Bekris
Published 2021-06-01
Article -
2
TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease by Jagan A. Pillai, Jagan A. Pillai, Jagan A. Pillai, Gurkan Bebek, Gurkan Bebek, Maria Khrestian, Maria Khrestian, James Bena, Cornelia C. Bergmann, William S. Bush, James B. Leverenz, James B. Leverenz, James B. Leverenz, Lynn M. Bekris, Lynn M. Bekris
Published 2021-02-01
Article -
3
-
4
Correlation between brain volume and retinal photoreceptor outer segment volume in normal aging and neurodegenerative diseases. by Atsuro Uchida, Jagan A Pillai, Robert Bermel, Stephen E Jones, Hubert Fernandez, James B Leverenz, Sunil K Srivastava, Justis P Ehlers
Published 2020-01-01
Article -
5
Metabolic syndrome biomarkers relate to rate of cognitive decline in MCI and dementia stages of Alzheimer’s disease by Jagan A. Pillai, James Bena, Lynn Bekris, Nandan Kodur, Takhar Kasumov, James B. Leverenz, Sangeeta R. Kashyap, on behalf of the Alzheimer’s Disease Neuroimaging Initiative
Published 2023-03-01
Article -
6
-
7
Inflammatory pathway analytes predicting rapid cognitive decline in MCI stage of Alzheimer’s disease by Jagan A. Pillai, James Bena, Gurkan Bebek, Lynn M. Bekris, Aaron Bonner‐Jackson, Lei Kou, Akshay Pai, Lauge Sørensen, Mads Neilsen, Stephen M. Rao, Mark Chance, Bruce T. Lamb, James B. Leverenz, the Alzheimer’s Disease Neuroimaging Initiative
Published 2020-07-01
Article